F. Charbonnier

2.0k total citations · 1 hit paper
11 papers, 1.6k citations indexed

About

F. Charbonnier is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, F. Charbonnier has authored 11 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in F. Charbonnier's work include Genetic factors in colorectal cancer (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Prion Diseases and Protein Misfolding (2 papers). F. Charbonnier is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Prion Diseases and Protein Misfolding (2 papers). F. Charbonnier collaborates with scholars based in France and Mexico. F. Charbonnier's co-authors include Thierry Frébourg, Cosette Martin, B Paillot, Pierre Michel, Jean‐Michel Flaman, Florence Le Pessot, A. Lamy, Frédéric Blanchard, Viviane Moreau and Frédéric Di Fiore and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

F. Charbonnier

10 papers receiving 1.5k citations

Hit Papers

Clinical relevance of KRA... 2007 2026 2013 2019 2007 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Charbonnier France 8 992 594 420 325 301 11 1.6k
Annie S.Y. Chan China 19 581 0.6× 1.1k 1.8× 366 0.9× 168 0.5× 465 1.5× 20 1.8k
Ian A.J. Lorimer Canada 21 518 0.5× 710 1.2× 132 0.3× 308 0.9× 399 1.3× 41 1.3k
Stefanie S. Schalm United States 13 428 0.4× 1.5k 2.5× 160 0.4× 387 1.2× 309 1.0× 19 2.0k
Peter Staller Germany 12 886 0.9× 1.9k 3.2× 129 0.3× 246 0.8× 653 2.2× 12 2.6k
Matthias Drosten Spain 22 777 0.8× 1.4k 2.4× 301 0.7× 261 0.8× 291 1.0× 43 2.0k
Chiping Qian United States 18 572 0.6× 1.3k 2.1× 191 0.5× 198 0.6× 267 0.9× 24 1.7k
Michael L. Major United States 12 417 0.4× 1.9k 3.2× 409 1.0× 142 0.4× 290 1.0× 12 2.0k
Hisaki Igarashi Japan 25 389 0.4× 945 1.6× 219 0.5× 322 1.0× 289 1.0× 52 1.5k
Andrew B. Gladden United States 18 724 0.7× 1.1k 1.9× 157 0.4× 209 0.6× 178 0.6× 26 1.7k
Dean B. Reardon United States 18 595 0.6× 791 1.3× 89 0.2× 315 1.0× 232 0.8× 23 1.4k

Countries citing papers authored by F. Charbonnier

Since Specialization
Citations

This map shows the geographic impact of F. Charbonnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Charbonnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Charbonnier more than expected).

Fields of papers citing papers by F. Charbonnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Charbonnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Charbonnier. The network helps show where F. Charbonnier may publish in the future.

Co-authorship network of co-authors of F. Charbonnier

This figure shows the co-authorship network connecting the top 25 collaborators of F. Charbonnier. A scholar is included among the top collaborators of F. Charbonnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Charbonnier. F. Charbonnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ferguson, Bruce G., et al.. (2019). Herbicidas en la milpa: Estrategias de aplicación y su impacto sobre el consumo de arvenses. SHILAP Revista de lepidopterología. 6(18). 7 indexed citations
2.
Fiore, F. Di, Frédéric Bibeau, A. Lamy, et al.. (2009). TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy. British Journal of Cancer. 100(8). 1330–1335. 72 indexed citations
3.
Fiore, Frédéric Di, Frédéric Blanchard, F. Charbonnier, et al.. (2007). Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. British Journal of Cancer. 96(8). 1166–1169. 621 indexed citations breakdown →
4.
Fiore, Frédéric Di, Florence Le Pessot, A. Lamy, et al.. (2007). KRAS mutation is highly predictive of cetuximab resistance in metastatic colorectal cancer. Journal of Clinical Oncology. 25(18_suppl). 10502–10502. 6 indexed citations
5.
Charbonnier, F., et al.. (2004). CORRECTION. Journal of Medical Genetics. 41(1). 20–20.
6.
Robert, Valérie, Pierre Michel, Jean‐Michel Flaman, et al.. (2000). High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis. 21(4). 563–565. 51 indexed citations
7.
Charbonnier, F., Grégory Raux, Qing Wang, et al.. (2000). Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments.. PubMed. 60(11). 2760–3. 144 indexed citations
8.
Dumanchin, Cécile, A. Camuzat, Dominique Campion, et al.. (1998). Segregation of a Missense Mutation in the Microtubule-Associated Protein Tau Gene with Familial Frontotemporal Dementia and Parkinsonism. Human Molecular Genetics. 7(11). 1825–1829. 184 indexed citations
9.
Campion, Dominique, Alexis Brice, Didier Hannequin, et al.. (1996). No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group.. Journal of Medical Genetics. 33(8). 661–664. 17 indexed citations
10.
Mauillon, Jacques, Michel Pierre, Jean‐Marc Limacher, et al.. (1996). Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer.. PubMed. 56(24). 5728–33. 66 indexed citations
11.
Flaman, Jean‐Michel, Thierry Frébourg, Viviane Moreau, et al.. (1995). A simple p53 functional assay for screening cell lines, blood, and tumors.. Proceedings of the National Academy of Sciences. 92(9). 3963–3967. 383 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026